These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 4218686

  • 1. Clinical experience with dihydroergocristine-reserpine-clopamide combination (brinerdin) in Ghanaian hypertensives.
    Bandoh JK.
    Ghana Med J; 1973 Jun; 12(2):166-76. PubMed ID: 4218686
    [No Abstract] [Full Text] [Related]

  • 2. A clinical trial of reserpine--clopamide--dihydroergocristine in the treatment of hypertension.
    Tantbirojn P.
    J Med Assoc Thai; 1974 Nov; 57(11):574-7. PubMed ID: 4217815
    [No Abstract] [Full Text] [Related]

  • 3. [DCR-515 (Brinerdin) in ambulatory treatment of hypertension].
    Vorburger C, Weisser HJ, Nanzer A, Halpern A.
    Ther Umsch; 1970 Mar; 27(3):188-94. PubMed ID: 4985524
    [No Abstract] [Full Text] [Related]

  • 4. [The use of brinerdin in the long-term treatment of moderate essential hypertension (author's transl)].
    Feuardent R.
    Schweiz Rundsch Med Prax; 1974 Nov 26; 63(47):1409-12. PubMed ID: 4216015
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic experiences with the antihypertensive combination "Briserin"].
    Nassehi AT.
    Med Klin; 1970 Oct 23; 65(43):1884-8. PubMed ID: 4990933
    [No Abstract] [Full Text] [Related]

  • 6. [On several anti-hypertensive drugs with special reference to the association of dihydroergocristine, reserpine and clopamide].
    Martinetti L, Lai G.
    Arch Maragliano Patol Clin; 1970 Oct 23; 26(3):209-18. PubMed ID: 5002193
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experience report on the combination antihypertensive agents DCR 1015 and DCR 515].
    Obrowsky L, Kern H.
    Wien Med Wochenschr; 1969 Jan 11; 119(2):36-9. PubMed ID: 4976539
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of hypertension with a combination of reserpine, the saluretic clopamide and the -adrenoblockader dihydroergocristine].
    Britov AN, Grebeshkova LM.
    Kardiologiia; 1972 Jun 11; 12(6):46-50. PubMed ID: 4626397
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy of pregnancy hypertension with Briserin].
    Neubüser D.
    Munch Med Wochenschr; 1971 Apr 30; 113(18):697-702. PubMed ID: 4996491
    [No Abstract] [Full Text] [Related]

  • 10. [Further clinico-therapeutic aspects of therapy of arterial hypertension].
    Anselmo B, Basso L.
    Clin Ter; 1971 Jan 15; 56(1):55-70. PubMed ID: 5002870
    [No Abstract] [Full Text] [Related]

  • 11. [Orientation studies with a new antihypertensive agent].
    Hugl E.
    Med Welt; 1968 Mar 30; 13():830-3. PubMed ID: 4974636
    [No Abstract] [Full Text] [Related]

  • 12. [A new effective antihypertensive agent. Studies on 40 patients].
    Bott H, Lill G.
    Med Welt; 1968 Mar 30; 13():834-6. PubMed ID: 4974637
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of hypertension].
    Kulke H.
    Fortschr Med; 1972 Dec 21; 90(35):1318-20. PubMed ID: 4633069
    [No Abstract] [Full Text] [Related]

  • 14. [Use of DCR-515 in the treatment of arterial hypertension].
    da Cunha GP, Riskala R, Mulinari AS.
    Hospital (Rio J); 1968 Dec 21; 74(6):2061-72. PubMed ID: 4977024
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of briserine, a hypotensive agent].
    Kargul W.
    Wiad Lek; 1975 Mar 15; 28(6):445-9. PubMed ID: 804213
    [No Abstract] [Full Text] [Related]

  • 16. [Kidney function during therapy of hypertension].
    Kiesewetter E, Wohlzogen FX, Mostbeck A.
    Int J Clin Pharmacol; 1973 Jul 15; 7(4):316-22. PubMed ID: 4199251
    [No Abstract] [Full Text] [Related]

  • 17. [Hypertension therapy with Briserin: what role do dihydroergocristine components play?].
    Schardt F, Polzien P.
    Med Klin; 1981 Dec 18; 76(26):746-52. PubMed ID: 6798382
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of hypertension using a combination of clopamide, dihydroergocristine and reserpine. Clinico-pharmacological studies using biometric evaluation].
    Szám I, Sólyom I, Fischer J.
    Med Monatsschr; 1970 Jan 18; 24(1):28-34. PubMed ID: 5525019
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
    Wanner J.
    Schweiz Med Wochenschr; 1968 Aug 10; 98(32):1196-201. PubMed ID: 4974016
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (preliminary communication)].
    Elizalde JE.
    Hospital (Rio J); 1968 Dec 10; 74(6):2073-5. PubMed ID: 4977025
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.